See the DrugPatentWatch profile for vascepa

Based on the information available, there is no evidence to suggest that Vascepa, a prescription medication used to lower triglyceride levels, triggers allergies in people who are sensitive to shellfish. Vascepa is a formulation of ethyl icosapentate, a highly purified eicosapentaenoic acid (EPA) [1]. The active ingredient in Vascepa, EPA, is not derived from shellfish or any other animal sources [1].

It is important to note that some individuals may have allergies to certain components of the medication itself, unrelated to shellfish. As with any medication, patients should discuss any allergies or concerns with their healthcare provider before starting Vascepa [1].

In summary, based on the information available, there is no evidence to suggest that Vascepa triggers allergies in people who are sensitive to shellfish.

Sources:
[1] Vascepa (ethyl icosapentate) [prescribing information]. Amarin Pharma Inc.; 2021. Accessed February 21, 2023. <https://www.vascepa.com/-/media/Files/Vascepa/Prescribing-Information.pdf>